Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T83335
(Former ID: TTDI01295)
|
|||||
Target Name |
Human immunodeficiency virus Transmission (HIV Tran)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Bacterial infection [ICD-11: 1A00-1C4Z] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | Ushercell | Drug Info | Phase 3 | Bacterial infection | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | Ushercell | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Short Communication: Enhancement of HIV Infection by Cellulose Sulfate. AIDS Res Hum Retroviruses. 2008 July; 24(7): 925-929. | |||||
REF 2 | Final HIV Results of Ushercell Trials Presented at IAS Conference in Sydney. Phase III Trials of Cellulose Sulfate Microbicide for HIV Prevention Closed. Arlington, VA, January 31, 2007. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.